BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2018
View Archived Issues
Predicting chemotherapy synergies
Read More
Repair cells can make things worse in neuromuscular disease
Read More
New arthritis severity gene id'd
Read More
Mortalin Kombat: Lysosomal inhibitor findings have cancer therapy implications
Read More
Award for Logic Biosciences' LBS-101 for oral mucositis
Read More
Mouse model reveals role of amylin signaling in POMC neurons in food intake, energy metabolism
Read More
Circadian regulation through MTNR1A contributes to the pathological cascade of Alzheimer's disease
Read More
SliC, a lysozyme-binding lipoprotein of N. gonorrhoeae with a key role during host colonization
Read More
Gut microbiota-derived metabolite TMAO found elevated in patients with Alzheimer's disease
Read More
ABL Bio and I-Mab enter immuno-oncology partnering agreement
Read More
Rxulti approved in E.U. for schizophrenia
Read More
European Commission approves Pfizer trastuzumab biosimilar Trazimera
Read More
Purdue completes phase Ib study of small molecule for insomnia associated with alcohol cessation
Read More
Myalepta approved for lipodystrophy in E.U.
Read More
Asterias releases Cohort 3 and 4 data from phase I/IIa SCiStar trial in severe spinal cord injury
Read More
European Commission approves Xeljanz for ulcerative colitis
Read More
Neuralstem begins phase II study of NSI-566 for ischemic stroke
Read More
NeuroActiva presents phase I data for NA-831 for Alzheimer's disease
Read More
New kinase inhibitors developed at IMPACT Therapeutics
Read More
Enanta Pharmaceuticals identifies respiratory syncytial virus inhibitors
Read More
ViiV Healthcare UK patents HIV integrase inhibitors
Read More
TGF-beta receptor type-1/2 inhibitors discovered at Bristol-Myers Squibb
Read More
Renji Hospital synthesizes aaptamine alkaloid derivatives
Read More
New phase I trial explores use of CERC-301 for neurogenic orthostatic hypotension in Parkinson's
Read More